CN111320580B - Preparation method of Lunvatinib intermediate - Google Patents
Preparation method of Lunvatinib intermediate Download PDFInfo
- Publication number
- CN111320580B CN111320580B CN201811536337.9A CN201811536337A CN111320580B CN 111320580 B CN111320580 B CN 111320580B CN 201811536337 A CN201811536337 A CN 201811536337A CN 111320580 B CN111320580 B CN 111320580B
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- formula
- formula iii
- molar amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 150000001875 compounds Chemical class 0.000 claims abstract description 80
- 238000006243 chemical reaction Methods 0.000 claims abstract description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 22
- 238000002425 crystallisation Methods 0.000 claims abstract description 10
- 230000008025 crystallization Effects 0.000 claims abstract description 10
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims abstract description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 20
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 16
- 238000007098 aminolysis reaction Methods 0.000 claims description 14
- 238000005917 acylation reaction Methods 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 12
- AHWALFGBDFAJAI-UHFFFAOYSA-N phenyl carbonochloridate Chemical compound ClC(=O)OC1=CC=CC=C1 AHWALFGBDFAJAI-UHFFFAOYSA-N 0.000 claims description 12
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 claims description 11
- 239000011230 binding agent Substances 0.000 claims description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 10
- 239000007810 chemical reaction solvent Substances 0.000 claims description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 5
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 3
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 3
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-diisopropylethylamine Substances CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 2
- 239000012295 chemical reaction liquid Substances 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 239000002585 base Substances 0.000 claims 3
- 239000003513 alkali Substances 0.000 claims 1
- 239000002516 radical scavenger Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 238000011084 recovery Methods 0.000 abstract description 4
- 239000002699 waste material Substances 0.000 abstract description 4
- 230000007613 environmental effect Effects 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 3
- OFQLBCBNNWFEPV-UHFFFAOYSA-N 4-(4-amino-3-chlorophenoxy)-7-methoxyquinoline-6-carboxamide Chemical compound C=12C=C(C(N)=O)C(OC)=CC2=NC=CC=1OC1=CC=C(N)C(Cl)=C1 OFQLBCBNNWFEPV-UHFFFAOYSA-N 0.000 description 22
- WOSKHXYHFSIKNG-UHFFFAOYSA-N lenvatinib Chemical compound C=12C=C(C(N)=O)C(OC)=CC2=NC=CC=1OC(C=C1Cl)=CC=C1NC(=O)NC1CC1 WOSKHXYHFSIKNG-UHFFFAOYSA-N 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 238000012544 monitoring process Methods 0.000 description 9
- 238000005070 sampling Methods 0.000 description 9
- 238000001816 cooling Methods 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 238000001914 filtration Methods 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- UWXSAYUXVSFDBQ-CYBMUJFWSA-N 4-n-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-n-[(4r)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]quinazoline-4,6-diamine Chemical compound C[C@@H]1COC(NC=2C=C3C(NC=4C=C(Cl)C(OCC=5SC=CN=5)=CC=4)=NC=NC3=CC=2)=N1 UWXSAYUXVSFDBQ-CYBMUJFWSA-N 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000012065 filter cake Substances 0.000 description 3
- 229950006605 varlitinib Drugs 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 229960003784 lenvatinib Drugs 0.000 description 2
- 238000004537 pulping Methods 0.000 description 2
- ZZUOWRXMZNMHCL-UHFFFAOYSA-N 2-(4-amino-3-chlorophenoxy)-7-methoxyquinoline-6-carboxamide Chemical compound NC1=C(C=C(OC2=NC3=CC(=C(C=C3C=C2)C(=O)N)OC)C=C1)Cl ZZUOWRXMZNMHCL-UHFFFAOYSA-N 0.000 description 1
- PNLPXABQLXSICH-UHFFFAOYSA-N 4-amino-3-chlorophenol Chemical compound NC1=CC=C(O)C=C1Cl PNLPXABQLXSICH-UHFFFAOYSA-N 0.000 description 1
- ZBTVNIDMGKZSGC-UHFFFAOYSA-N 4-chloro-7-methoxyquinoline-6-carboxamide Chemical compound C1=CC(Cl)=C2C=C(C(N)=O)C(OC)=CC2=N1 ZBTVNIDMGKZSGC-UHFFFAOYSA-N 0.000 description 1
- 240000006570 Euonymus japonicus Species 0.000 description 1
- 235000016796 Euonymus japonicus Nutrition 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 208000015799 differentiated thyroid carcinoma Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 229940124617 receptor tyrosine kinase inhibitor Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (21)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811536337.9A CN111320580B (en) | 2018-12-14 | 2018-12-14 | Preparation method of Lunvatinib intermediate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811536337.9A CN111320580B (en) | 2018-12-14 | 2018-12-14 | Preparation method of Lunvatinib intermediate |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111320580A CN111320580A (en) | 2020-06-23 |
CN111320580B true CN111320580B (en) | 2022-12-20 |
Family
ID=71166946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811536337.9A Active CN111320580B (en) | 2018-12-14 | 2018-12-14 | Preparation method of Lunvatinib intermediate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111320580B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113372270A (en) * | 2021-06-24 | 2021-09-10 | 江西国药有限责任公司 | Lunvatinib and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106660964A (en) * | 2014-08-28 | 2017-05-10 | 卫材R&D管理有限公司 | High-purity quinoline derivative and method for manufacturing same |
CN107739335A (en) * | 2017-12-01 | 2018-02-27 | 南京奇可药业有限公司 | A kind of pleasure cuts down the synthetic method for Buddhist nun |
CN108299294A (en) * | 2017-01-11 | 2018-07-20 | 江苏恒瑞医药股份有限公司 | A kind of pleasure is cut down for the preparation method of Buddhist nun's impurity |
WO2018145621A1 (en) * | 2017-02-07 | 2018-08-16 | 恩瑞生物医药科技(上海)有限公司 | Quinoline compound, preparation method and medical use therefor |
CN108623521A (en) * | 2018-03-22 | 2018-10-09 | 盐城师范学院 | A kind of pleasure cuts down the preparation method for Buddhist nun |
CN108658859A (en) * | 2017-03-30 | 2018-10-16 | 中国科学院成都有机化学有限公司 | A kind of pleasure cuts down the synthetic method for Buddhist nun |
-
2018
- 2018-12-14 CN CN201811536337.9A patent/CN111320580B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106660964A (en) * | 2014-08-28 | 2017-05-10 | 卫材R&D管理有限公司 | High-purity quinoline derivative and method for manufacturing same |
CN108299294A (en) * | 2017-01-11 | 2018-07-20 | 江苏恒瑞医药股份有限公司 | A kind of pleasure is cut down for the preparation method of Buddhist nun's impurity |
WO2018145621A1 (en) * | 2017-02-07 | 2018-08-16 | 恩瑞生物医药科技(上海)有限公司 | Quinoline compound, preparation method and medical use therefor |
CN108658859A (en) * | 2017-03-30 | 2018-10-16 | 中国科学院成都有机化学有限公司 | A kind of pleasure cuts down the synthetic method for Buddhist nun |
CN107739335A (en) * | 2017-12-01 | 2018-02-27 | 南京奇可药业有限公司 | A kind of pleasure cuts down the synthetic method for Buddhist nun |
CN108623521A (en) * | 2018-03-22 | 2018-10-09 | 盐城师范学院 | A kind of pleasure cuts down the preparation method for Buddhist nun |
Also Published As
Publication number | Publication date |
---|---|
CN111320580A (en) | 2020-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0634997A1 (en) | Preparation of substituted guanidines | |
CN111320580B (en) | Preparation method of Lunvatinib intermediate | |
KR101357664B1 (en) | METHOD FOR PREPARING 4β-AMINO-4'-DEMETHYL-4-DESOXYPODOPHYLLOTOXIN | |
CN112094212A (en) | Preparation method of montelukast sodium side chain | |
CN113121499B (en) | Synthetic method and application of omeprazole | |
CN106543144A (en) | A kind of industrialized process for preparing of dabigatran etcxilate | |
CN111285821A (en) | Method for continuously preparing febuxostat | |
CN104788336A (en) | Synthesis method of imide compound | |
US7323568B2 (en) | Process for preparing Imiquimod | |
CN111018782A (en) | Preparation method of 9-aminoacridine and derivatives thereof | |
CN109678858A (en) | A kind of preparation method of folic acid | |
CN112552345A (en) | Preparation method of NK-1 receptor antagonist | |
JP2006193444A (en) | Method for producing 4,4'-dicarboxy-2,2'-bipyridine | |
CN111423342A (en) | Preparation method for co-production of N-methyl-2-fluoroaniline and crystalline sulfanilamide | |
CN111777576A (en) | Preparation method of nintedanib key intermediate | |
CN108997252B (en) | Green synthesis method of oxadiazole derivative | |
CN118146182B (en) | Preparation method of 3-benzyloxy-4-oxo-4H-pyran-2-carboxylic acid | |
CN111484458B (en) | Preparation method of 2-hydroxy-5-sulfonic pyrimidine | |
WO2006128688B1 (en) | Process for the preparation of pramipexole | |
CN113999169B (en) | Preparation method of fluroxypyr-meptyl | |
CN118184627A (en) | Method for preparing An Luoti Ni | |
CN111004193A (en) | Preparation method of cariprazine | |
CN117362227A (en) | Synthesis method of quinolone carboxylic ester | |
CN116621781A (en) | Preparation method of 2- (3-nitrophenyl) -4, 5-dihydro-1H-imidazoline | |
CN113214181A (en) | New preparation method of mosapride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230808 Address after: No. 20 Yaogu Yiheng Road, Xiuying District, Haikou City, Hainan Province, 570311 Patentee after: Xiansheng Zaiming Pharmaceutical Co.,Ltd. Address before: 210042 699 Xuanwu Road, Xuanwu District, Nanjing, Jiangsu -18 Patentee before: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No. 20 Yaogu Yiheng Road, Xiuying District, Haikou City, Hainan Province, 570311 Patentee after: Hainan Xiansheng Zaiming Pharmaceutical Co.,Ltd. Country or region after: China Address before: No. 20 Yaogu Yiheng Road, Xiuying District, Haikou City, Hainan Province, 570311 Patentee before: Xiansheng Zaiming Pharmaceutical Co.,Ltd. Country or region before: China |